QA: FIBROGEN INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000921299_2023_FIBROGEN_INC.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000921299, FIBROGEN INC

  xvar xval
0 AssetsCurrent 492,826,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 20,605,000
3 remainder_Assets 96,656,000
4 LiabilitiesCurrent 273,562,000
5 LiabilitiesNoncurrent 271,755,000
6 remainder_Liabilities 66,250,000
7 CostOfGoodsAndServicesSold 20,280,000
8 SellingGeneralAndAdministrativeExpense 124,688,000
9 ResearchAndDevelopmentExpense 296,791,000
10 remainder_Expenses 358,000
11 remainder_Revenues 140,734,000
12 remainder_NetIncome 7,729,000
13 remainder_ComprehensiveNetIncome -1,557,000
  yvar yval
0 Assets 610,087,000
1 Liabilities 611,567,000
2 Expenses 442,117,000
3 Revenues 140,734,000
4 StockholdersEquity -1,480,000
5 NetIncome -293,654,000
6 ComprehensiveNetIncome -294,432,500
7 BaseVar 906,895,500
8 EconomicCapitalRatio -0.486

Edgar->Model Mapping

Feature Distribution

Change over Time